SEC Form 4 · accession 0001171843-18-000697
Anika Therapeutics, Inc. · ANIK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve E Wheeler
Director
Period of report
Jan 24, 2018
Accepted (ET)
Jan 26, 2018 · 4:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000898437
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 22, 2016 | J | 1,955 | $0.00 | D | 34,126 | D | |
| Common StockF2 | Feb 16, 2017 | J | 1,158 | $0.00 | D | 32,968 | D | |
| Common StockF3 | Jan 24, 2018 | A | 1,626 | $0.00 | A | 34,594 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The total number of shares beneficially owned by the reporting person was incorrectly stated in Column 5 of the Form 4 filed by the reporting person on January 31, 2017. That total share number included these 1,955 shares, which were transferred on December 22, 2016 pursuant to a settlement agreement effective June 12, 2014.
- F2These shares were transferred on February 16, 2017 pursuant to a settlement agreement effective June 12, 2014.
- F3These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on January 24, 2019.